MedPath
Found 7 clinical trials|View Analysis
Sort by:

Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated With Targeted Therapy

Not Applicable
Recruiting
Conditions
Leukemia,Myeloid, Chronic
Interventions
Biological: Blood and bone marrow sample
First Posted Date
2023-11-14
Last Posted Date
2024-07-08
Lead Sponsor
University Hospital, Clermont-Ferrand
Target Recruit Count
321
Registration Number
NCT06130787
Locations
🇫🇷

Centre Hospitalier Emile Roux, Le Puy-en-Velay, France

🇫🇷

CHU Annecy-Genevois, Annecy, France

🇫🇷

Institut Bergonié, Bordeaux, France

and more 14 locations

An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors

Not Applicable
Recruiting
Conditions
Hematologic Cancer
Solid Tumor, Childhood
Solid Tumor, Adult
Interventions
Procedure: Tumor biopsy
Procedure: Blood sample
Procedure: Bone marrow sample
First Posted Date
2022-08-01
Last Posted Date
2024-08-14
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Target Recruit Count
160
Registration Number
NCT05481502
Locations
🇫🇷

Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France

Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia

Not Applicable
Recruiting
Conditions
Waldenstrom Macroglobulinemia
Hyperviscosity Syndrome
Interventions
Other: fundoscopic picture
Biological: blood sample
Procedure: bone marrow sample
First Posted Date
2021-05-24
Last Posted Date
2023-02-10
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Target Recruit Count
100
Registration Number
NCT04898647
Locations
🇫🇷

CHU Amiens, Amiens, France

Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker

Recruiting
Conditions
Purpura, Thrombocytopenic
Myelodysplastic Syndromes
Thrombocytopenia
Interventions
Procedure: blood sample
Procedure: Bone marrow sample
First Posted Date
2019-07-01
Last Posted Date
2022-11-28
Lead Sponsor
University Hospital, Bordeaux
Target Recruit Count
80
Registration Number
NCT04003220
Locations
🇫🇷

Immunopathologie Clinique - Hôpital Saint Louis - AP HP, Paris, France

🇫🇷

Chirurgie cardiaque - Hôpital Haut Lévêque - CHU de Bordeaux, Pessac, France

🇫🇷

Service des maladies du sang - Hôpital Haut-Lévêque - avenue de Magellan, Pessac, France

and more 1 locations

Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation

Not Applicable
Conditions
Immune Evasion, Tumor
Allogeneic Stem Cell Transplantation
Relapse Leukemia
Interventions
Biological: blood sample
Biological: bone marrow sample
First Posted Date
2019-05-28
Last Posted Date
2019-05-28
Lead Sponsor
Central Hospital, Nancy, France
Target Recruit Count
104
Registration Number
NCT03964922

Study of Dendrogenin A / Oxysterols Balance Between Healthy Volunteers and Acute Myeloid Leukemia Patients

Not Applicable
Completed
Conditions
Acute Myeloid Leukemia
Interventions
Biological: Blood sample
Biological: Bone marrow sample
First Posted Date
2015-11-11
Last Posted Date
2019-05-13
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
37
Registration Number
NCT02602587
Locations
🇫🇷

Chu Toulouse, Toulouse, France

Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia

Phase 1
Conditions
Critical Limb Ischemia
Peripheral Arterial Disease
Buerger's Disease
Interventions
Device: ResQ processed bone marrow sample
Device: Ficoll conventional cell processing method
First Posted Date
2011-10-04
Last Posted Date
2011-10-12
Lead Sponsor
Xuanwu Hospital, Beijing
Target Recruit Count
50
Registration Number
NCT01446055
Locations
🇨🇳

Xuan Wu Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath